期刊文献+

雌激素受体基因多态性与冠心病关系的研究 被引量:9

Association of estrogen receptor gene polymorphisms with coronary heart disease
原文传递
导出
摘要 目的 观察雌激素受体 (ER)基因多态性在中国汉族人群中的分布及其与冠心病 (CHD)的关系。方法 应用聚合酶链反应 (PCR)和限制性片段长度多态性 (RFLP)方法检测 1 35例CHD患者和 1 1 8例正常对照者ER基因型 ,结合血脂水平、选择性冠状动脉造影 (SCA)结果探讨两者间的关系。结果 ER等位基因X、x和P、p频率在冠心病组和对照组分别为 0 1 70、0 830 ,0 1 69、0 831 ;0 2 56、0 744,0 339、0 661。基因型频率分布符合Hardy Weinberg平衡定律。XbaⅠ酶切多态性基因型频率、等位基因频率及结合XbaⅠ和PvuⅡ两个酶切多态性分析在组内、组间比较差异均无显著性 (P >0 0 5) ,且ER基因型间血脂水平、SCA结果在组内比较均无统计学意义 (P >0 0 5)。但是 ,PvuⅡ酶切多态性在正常对照组与CHD组以及心肌梗死组与心绞痛组比较有明显差异 (P <0 0 5)。结论 在CHD人群中存在着ERXbaⅠ和PvuⅡ基因多态性 ,其中XbaⅠ酶切多态性与CHD无相关性 (P >0 0 5) ,而ERPvuⅡ酶切多态性与冠心病有相关性 (P <0 0 5) ,PvuⅡ基因多态性可能是CHD发病的危险因素之一。 Objective To study the distribution of estrogen receptor(ER) polymorphisms in Chinese Han population and the association of the polymorphisms with coronary heart disease(CHD) Methods ER genotyping was performed in 135 CHD patients and 118 controls by using PCR RFLP method The serum lipid levels were also determined Selected coronary angiography(SCA) were performed in 46 CHD patients Results ER allelic frequencies of X,x and P, p alleles were 0 170, 0 830; 0 169, 0 831 and 0 256, 0 744, 0 399, 0 661 in CHD group and control group respectively There was no significant difference in frequencies of allele and genotype in XbaI polymorphism or XbaI with PvuII polymorphisms together between CHD group and control group ( P >0 05). The serum lipid levels and the results of SCA were also not significantly different among genotypes within group However, the distribution of PvuII genotypes was significantly different between the two groups or between myocardial infarction subgroup and angina pectoris subgroup ( P <0 05), respectively Conclusion XbaI polymorphism is not related to CHD, but PvuII polymorphism is associated with CHD and might be a risk factor for CHD
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2002年第2期78-81,共4页 Chinese Journal of Cardiology
基金 湖北省自然科学基金( 2 0 0 0J0 70 )
关键词 雌激素受体 遗传学 脂蛋白类 冠心病 基因多态性 Receptor, estrogen Polymorphism (Geneties) Serum lipid Coronary disease Lipoproteins
  • 相关文献

参考文献7

  • 1Hanke H, Hanke S, Bruck B, et al. Inhibition of the protective effect of estr ogen by progesterone in experimental atherosclerosis. Atherosclerosis, 1996,121: 129-138.
  • 2Mariska AJ, Floore AN, Kim IM, et al. A functional assay in yeast for the hum an estrogen receptor desplays wild type and variant estrogen receptor messenger RNAs present in breast carcinona. Cancer Res, 1997,57:3478-3485.
  • 3Kobayshi S, Inoues S, Hosoi T, et al. Assoiation of bone mineral density with po lymorphism of the estrogen receptor gene. J Bone Miner Res, 1996,11:306-311.
  • 4Loparev VN, Cartas MA, Monken CE, et al. An efficient and simple method of DN A extraction from whole blood and cell lines to identify infectious agents. J Vi rol Methods, 1991,34:105-112.
  • 5Carling T, Rastad J, Kindmark A, et al. Estrogen receptor gene polymorphism i n postmenopausal primary hyperparathyroidism. Surgery, 1997,122:1101-1105.
  • 6Deng HW, Li J, Li JL, et al. Charges of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet, 1998,103:576-585.
  • 7黄宪章,李艳.雌激素受体基因多态性的研究进展[J].国外医学(临床生物化学与检验学分册),2000,21(5):254-255. 被引量:17

二级参考文献1

  • 1Tone Ikdahl Anderson,Ketil Riddervold Heimdal,Martina Skrede,Kjell Tveit,K?re Berg,Anne-Lise B?rresen. Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility[J] 1994,Human Genetics(6):665~670

共引文献16

同被引文献99

引证文献9

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部